Total Payments
$53,279
2024 Payments
$12,262
Companies
17
Transactions
73
Medicare Patients
2,504
Medicare Billing
$425,706
Payment Breakdown by Category
Consulting$42,525 (79.8%)
Other$6,575 (12.3%)
Food & Beverage$2,546 (4.8%)
Travel$1,493 (2.8%)
Education$140.16 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,525 | 22 | 79.8% |
| Honoraria | $6,375 | 2 | 12.0% |
| Food and Beverage | $2,546 | 40 | 4.8% |
| Travel and Lodging | $1,493 | 5 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 0.4% |
| Education | $140.16 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Photocure Inc | $10,824 | 28 | $0 (2022) |
| Stryker Corporation | $10,114 | 9 | $0 (2024) |
| UROGEN PHARMA, INC. | $9,600 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $7,986 | 11 | $0 (2024) |
| Janssen Research & Development, LLC | $4,725 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $3,500 | 2 | $0 (2021) |
| COLOPLAST CORP | $2,813 | 4 | $0 (2021) |
| Seagen Inc. | $2,800 | 1 | $0 (2020) |
| Intuitive Surgical, Inc. | $313.56 | 2 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $197.91 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,262 | 12 | Stryker Corporation ($5,260) |
| 2023 | $78.71 | 2 | Ferring Pharmaceuticals Inc. ($48.70) |
| 2022 | $6,993 | 8 | Stryker Corporation ($4,837) |
| 2021 | $15,849 | 13 | UROGEN PHARMA, INC. ($9,600) |
| 2020 | $7,954 | 5 | Photocure Inc ($3,654) |
| 2019 | $8,839 | 15 | E.R. Squibb & Sons, L.L.C. ($4,866) |
| 2018 | $777.84 | 10 | Photocure Inc ($664.28) |
| 2017 | $525.07 | 8 | Photocure Inc ($501.28) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,010.00 | General |
| 12/13/2024 | Stryker Corporation | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/04/2024 | Astellas Pharma Global Development | Padcev (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Oncology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 11/01/2024 | Stryker Corporation | 1788 (Medical Supply) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: ENDOSCOPY | ||||||
| 10/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Immunotherapy | ||||||
| 08/06/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| 04/25/2024 | Stryker Corporation | — | Consulting Fee | Cash or cash equivalent | $1,260.00 | General |
| 02/15/2024 | Stryker Corporation | ICONIX (Device) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: SPORTS MEDICINE | ||||||
| 01/09/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Space OAR_URO | ||||||
| 11/29/2023 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Drug) | Food and Beverage | In-kind items and services | $48.70 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: rezum_URO | ||||||
| 12/14/2022 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $45.75 | General |
| 09/22/2022 | Stryker Corporation | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/31/2022 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2022 | Stryker Corporation | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 05/05/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2022 | Stryker Corporation | 1688 (Device) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: VISUALIZATION | ||||||
| 03/29/2022 | Stryker Corporation | L10 (Device) | Food and Beverage | In-kind items and services | $37.40 | General |
| Category: VISUALIZATION | ||||||
| 12/08/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/16/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $7.60 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2021 | Stryker Corporation | L10 (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: VISUALIZATION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 722 | 1,037 | $1.4M | $112,439 |
| 2022 | 15 | 666 | 906 | $1.2M | $110,744 |
| 2021 | 16 | 569 | 768 | $994,864 | $88,124 |
| 2020 | 17 | 547 | 726 | $1.2M | $114,398 |
Total Patients
2,504
Total Services
3,437
Medicare Billing
$425,706
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 238 | 478 | $607,538 | $29,601 | 4.9% |
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening | Facility | 2023 | 14 | 14 | $164,542 | $26,879 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 86 | 119 | $68,663 | $10,110 | 14.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 36 | 40 | $62,280 | $9,880 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 85 | 85 | $73,695 | $9,455 | 12.8% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 24 | 25 | $33,275 | $5,278 | 15.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 27 | 38 | $134,290 | $4,310 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 75 | $29,475 | $4,194 | 14.2% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 12 | 12 | $32,472 | $3,915 | 12.1% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 20 | 22 | $64,460 | $2,436 | 3.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 29 | 29 | $16,675 | $1,927 | 11.6% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 11 | 11 | $78,265 | $1,664 | 2.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 15 | 15 | $2,745 | $1,046 | 38.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 31 | 41 | $5,535 | $903.23 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 17 | 19 | $4,579 | $572.76 | 12.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Facility | 2023 | 14 | 14 | $9,954 | $266.84 | 2.7% |
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening | Facility | 2022 | 15 | 15 | $176,295 | $28,577 | 16.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 220 | 381 | $484,251 | $24,016 | 5.0% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 44 | 47 | $73,179 | $11,356 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 89 | 127 | $49,911 | $7,009 | 14.0% |
| 55840 | Removal of prostate | Facility | 2022 | 12 | 12 | $86,796 | $6,173 | 7.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 55 | 55 | $47,685 | $6,013 | 12.6% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2022 | 12 | 16 | $43,296 | $5,403 | 12.5% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 21 | 22 | $29,282 | $4,671 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 54 | 54 | $31,050 | $3,807 | 12.3% |
About Dr. Sima Porten, M.D
Dr. Sima Porten, M.D is a Urology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124157474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sima Porten, M.D has received a total of $53,279 in payments from pharmaceutical and medical device companies, with $12,262 received in 2024. These payments were reported across 73 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($42,525).
As a Medicare-enrolled provider, Porten has provided services to 2,504 Medicare beneficiaries, totaling 3,437 services with total Medicare billing of $425,706. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location San Francisco, CA
- Active Since 03/04/2007
- Last Updated 08/04/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1124157474
Products in Payments
- JELMYTO (Drug) $9,600
- Cysview (Drug) $8,714
- 1688 (Device) $3,600
- SpeediCath (Device) $2,813
- 1788 (Medical Supply) $2,800
- PADCEV (Biological) $2,800
- CYSVIEW (Drug) $2,110
- OPDIVO (Biological) $1,080
- ICONIX (Device) $800.00
- Da Vinci Surgical System (Device) $313.56
- ADSTILADRIN (Biological) $149.21
- INLYTA (Drug) $140.16
- XTANDI (Drug) $78.43
- L10 (Device) $53.97
- ADSTILADRIN (Drug) $48.70
- ANKTIVA (Drug) $32.32
- Rezum Generator (Device) $30.01
- SpaceOAR System (Device) $29.28
- Padcev (Drug) $25.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Francisco
Dr. Marshall Stoller, M.d, M.D
Urology — Payments: $340,565
Urology $340,565
Dr. Matthew Cooperberg, Md, MD
Urology — Payments: $115,087
Urology $115,087
Alvaro Santamaria, Md, MD
Urology — Payments: $55,685
Urology $55,685
Dr. Mang Chen, Md, MD
Urology — Payments: $49,472
Urology $49,472
Dr. Maxwell Meng, M.d, M.D
Urology — Payments: $41,583
Urology $41,583
Dr. Katsuto Shinohara, M.d, M.D
Urology — Payments: $36,583
Urology $36,583